Company intelligence / Profile preview

Bioniq

London, United Kingdom

Ownership: Private
Employees: ~100
Development stage: Other

Overview

Bioniq is a health-tech company specializing in personalized nutrition and wellness through blood-based biomarker analysis. The company's platform uses a proprietary AI algorithm, developed from a large database of clinical data, to formulate bespoke supplements for users. Customers undergo regular blood tests to monitor their health status, allowing Bioniq to adjust supplement compositions dynamically. Headquartered in London, the company operates globally, providing a subscription-based model that integrates diagnostics with tailored nutritional interventions.

Therapeutic areas: OtherMetabolic Disorders
Modalities: NutraceuticalsPersonalized supplements
Industry: Food & Nutrition

Beyond the preview

Go deeper on Bioniq.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bioniq.

Explore the full profile